Showing results (1-10 of 242) with videos related to
Sort By:
Pageof 25
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 1, 2003
The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe haemophilia AJ M Lusher, C A Lee, C M Kessler, et al.JAMA|June 16, 1989
The use of purified clotting factor concentrates in hemophilia. Influence of viral safety, cost, and supply on therapyG F Pierce, J M Lusher, A P Brownstein, et al.Transfusion Medicine Reviews|August 1, 1987
Management of patients with factor VIII inhibitorsJ M LusherBlood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 18, 1998
Recombinant activated factor VII for treatment of intramuscular haemorrhages: a comparison of early versus late treatmentJ M LusherAmerican Journal of Obstetrics and Gynecology|September 1, 1996
Screening and diagnosis of coagulation disordersJ M LusherBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 24, 2007
Recombinant clotting factors: a review of current clinical statusJ M LusherSeminars in Thrombosis and Hemostasis|August 5, 2000
Inhibitor antibodies to factor VIII and factor IX: managementJ M LusherBailliere'S Best Practice & Research. Clinical Haematology|October 13, 2000
Inhibitors in young boys with haemophiliaJ M LusherHaemostasis|September 1, 1994
Response to 1-deamino-8-D-arginine vasopressin in von Willebrand diseaseJ M LusherPageof 25